Israel Englander’s Millennium Management more than doubled its positions in $ABBV and $COST during Q2, showing strong conviction in both names.

AbbVie offers a higher-yield healthcare play, while Costco brings a strong brand, steady demand and a long track record of dividend growth.

When a billionaire investor makes moves this big, it’s definitely worth asking what he sees that the market might be missing.

Would you buy $ABBV or $COST right now?